NRX Pharmaceuticals, Inc. Payments to Acquire Investments
NRX Pharmaceuticals, Inc. (NRXP) reported Payments to Acquire Investments of $213.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2026-03-31 was $213.00K.
- NRX Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2025-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2020-03-31 was $192.52K.
- NRX Pharmaceuticals, Inc. payments to acquire investments for fiscal 2025 was $432.00K.
- NRX Pharmaceuticals, Inc. payments to acquire investments for fiscal 2024 was $0.00.
- NRX Pharmaceuticals, Inc. payments to acquire investments for fiscal 2020 was $282.63K, a 71.54% decline from fiscal 2019.
- NRX Pharmaceuticals, Inc. payments to acquire investments for fiscal 2019 was $993.10K, a 43.93% increase from fiscal 2018.
| Period end | Payments to Acquire Investments | Payments to Acquire Investments 3 month | Payments to Acquire Investments 12 month |
|---|---|---|---|
| 2026-03-31 | $213.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $432.00K 10-K · filed 2026-03-23 | ||
| 2025-10-17 | $432.00K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-21 | ||
| 2020-12-31 | $282.63K 10-K/A · filed 2021-05-14 | ||
| 2020-03-31 | $192.52K 10-Q · filed 2021-05-21 | ||
| 2019-12-31 | $993.10K 10-K/A · filed 2021-05-14 | ||
| 2018-12-31 | $690.00K 10-K · filed 2020-03-30 | ||
| 2017-12-31 | $69.00M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |